11th ISNS European Regional Meeting, Bratislava Slovakia; An Overview
Reflecting on a common concern in newborn screening: Reliability.
Advancing Diagnostic Screening with the RenataDX Screening System
Waters’ legacy of purposeful innovation continues with the recently introduced RenataDX Screening System, a flow-injection tandem mass spectrometry system for high-throughput analysis of extracted dried blood spots and other physiological matrices.
The Historical Role of Mass Spectrometry in Newborn Screening
Newborn screening for inherited metabolic disorders dates to the early 1960s when Dr. Robert Guthrie in Buffalo, New York developed the first screening test for phenylketonuria (or PKU), a metabolic disease in which patients can’t metabolize the amino acid phenylalanine.
Why Tandem Mass Spec is Essential for Newborn Screening
Mass spectrometry has been game changer in newborn screening because rather than having a single test for a single condition, there was now a technique that provided a single test for a large number of different conditions.
Webinar Highlights: Quantifying Cannabinoids in Oral Fluid to Determine Driving Impairment Following Marijuana Consumption
Q&A from a recent forensic toxicology webinar on using an ACQUITY UPLC I-Class/Xevo TQ-S micro MS system for quantifying cannabinoids in oral fluid.
A Week in the Life of Vicky Starkie, Customer Success Team
Meet Vicky, who joined Waters’ Customer Success Team about two years ago with 20 years of LC-MS experience. She specializes in clinical forensic and toxicological applications supporting customers in Northern Europe.
A Virus Gives Up One of Its Long-Held Secrets to Researchers at the National University of Singapore
Eradicating all the mosquitoes that may cause Dengue fever isn’t a realistic solution. Instead, researchers at the NUS are using advanced analytical technologies to understand what causes the virus to incubate and spread – and thus, to find a way to stop it.
Reducing the Frequency of Service Engineer Visits for LC-MS Maintenance to Annual Events
Labs like King’s Liver Laboratories in London need to analyze thousands of samples with fast turnaround times, so it’s critical to have reliable LC-MS/MS instrumentation that works every day and provides accurate and precise results.
A Day in the Life of Michelle Wood, R&D Toxicology Manager, Scientific Operations
Michelle and her team are responsible for identifying high-demand assays and developing appropriate LC-MS solutions for use in toxicology.
Advancing Omics Research and Reducing Bias with New MS Technology for Data-Independent Acquisition Experiments
Targeted LC-MS based assays are increasingly applied in the post-discovery Omics area with an emphasis on validation, the first of many phases in translational research; and in studies that are aimed at gaining the understanding of biological systems in terms of drug development and treatment. Understanding the context of analytical results is driving current research,…
Phenome Network: A Harmonized Research Consortium for Innovative Global Health
The world is facing an unprecedented convergence of environmental and lifestyle factors that dramatically increase our risk of chronic disease. Global warming, antimicrobial resistance, aging populations, and the prevalence of lifestyle-related illnesses are systematically affecting populations around the world and posing some of the greatest scientific and public health threats seen in modern times. These…
Do You See What We See? Mass Spectrometry Imaging is Revealing Insights in Biomedical Research
The spatial distribution of molecular species in a sample can provide a wealth of information about biological, chemical and physiological processes. Mass spectrometry (MS) imaging is a rapidly developing research technique that enables specific measurement of molecular targets at complex surfaces. This direct-from-sample analytical technique provides researchers with the information needed to quickly and objectively…